Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on SAGE THERAPEUTICS, INC.
02/25/21 FY 2020 Earnings Release (Projected)
05/06/21 Q1 2021 Earnings Release (Projected)
08/10/21 Interim 2021 Earnings Release (Projected)
11/11/21 Q3 2021 Earnings Release (Projected)
Past events on SAGE THERAPEUTICS, INC.
11/30/20 | 08:00am Biogen Inc and Sage Therapeutics, Inc Gobal Collaboration and License Agreement Call
11/19/20 | 04:05pm Wolfe Virtual Healthcare Conference
11/16/20 | 08:40am Stifel Healthcare Conference
11/05/20 | 08:30am Q3 2020 Earnings Call
Upcoming sector events for SAGE THERAPEUTICS, INC.
12/01/20 ULTRAGENYX PHARMACEUTICAL INC. : Piper Sandler Health Care Conference
12/01/20 | 04:00pm NOVAVAX, INC. : Piper Sandler Virtual Healthcare Conference
12/01/20 | 04:30pm REGENERON PHARMACEUTICALS, INC. : Evercore ISI HealthCONx Conference
12/01/20 | 09:05pm EXELIXIS, INC. : Evercore ISI HealthCONx Conference
More events
Past sector events for SAGE THERAPEUTICS, INC.
11/30/20 | 04:00pm CUREVAC N.V. : Q3 2020 Präsentation des Ergebnisses
11/30/20 CUREVAC N.V. : Q3 2020 Ergebnisveröffentlichung
11/26/20 | 08:00am HANGZHOU TIGERMED CONSULTING CO.,LTD : Ausserordentliche Aktionärsversammlung
11/24/20 | 02:00pm ALNYLAM PHARMACEUTICALS, INC. : OXLUMO FDA Approval Call
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread






90,3
90,0
0,30%
6,87
8,72
-21%

7,06
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-94,5
-93,3
-1,4%
-160
-140
-14%
-273
-285
4,4%
-392
-375
-4,5%
-706
-736
4,0%

-481
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-94,7
-93,5
-1,3%
-160
-144
-11%
-273
-282
3,2%
-393
-369
-6,6%
-708
-728
2,8%

-434
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-94,5
-94,0
-0,56%
-159
-144
-10%
-270
-279
3,0%
-373
-347
-7,4%
-680
-701
2,9%

-397
Net income
M $
Released
Forecast
Spread
-94,5
-93,4
-1,2%
-159
-144
-10%
-270
-279
3,3%
-373
-349
-6,8%
-680
-700
2,9%

-469
EPS
$
Released
Forecast
Spread
-3,40
-3,35
-1,6%
-4,75
-4,38
-8,4%
-7,09
-7,38
3,9%
-8,08
-7,54
-7,1%
-13,4
-13,8
2,7%

-8,02
Announcement Date02/24/201602/23/201702/22/201802/19/201902/27/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
3,57
2,52
41%
1,96
3,76
-48%
2,30
2,81
-18%
1,09
0,88
24%
1,64
1,85
-11%

1,95
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-186
-183
-1,8%
-174
-204
15%
-131
-178
26%
-110
-141
22%
-107
-137
22%

-115
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-187
-182
-2,6%
-175
-194
10%
-132
-171
23%
-111
-141
22%
-108
-127
15%

-48,6
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-180
-176
-2,1%
-169
-189
11%
-127
-167
24%
-136
-143
4,9%
-106
-127
17%

-30,9
Net income
M $
Released
Forecast
Spread
-180
-176
-2,1%
-169
-188
10%
-127
-166
24%
-136
-140
2,6%
-106
-125
15%

-104
EPS
$
Released
Forecast
Spread
-3,48
-3,41
-2,1%
-3,25
-3,62
10%
-2,44
-3,19
24%
-2,63
-2,69
2,3%
-2,03
-2,37
14%

-1,06
Announcement Date11/12/201902/27/202005/07/202008/10/202011/05/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise